Segmentectomy Versus Lobectomy for Radiologically Pure Solid Clinical T1a-bN0M0 Lung Cancer. 2018

Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
Department of Surgical Oncology, Hiroshima University, 1-2-3 Kasumi, Minami-ku, Hiroshima, 734-8551, Japan.

Segmentectomy for radiologically pure solid tumors is still controversial because these tumors are more aggressive in malignancy than those with ground-glass opacity. This study aimed to determine the feasibility of intentional segmentectomy for pure solid small-sized lung cancer. We retrospectively analyzed 96 radiologically pure solid tumors in clinical T1a-bN0M0 lung cancer. Patients whose tumor was located at a central region or right middle lobe were excluded. Forty-four patients who underwent lobectomy were compared with 52 those who underwent segmentectomy. Segmentectomy got converted to lobectomy if lymph node metastases or inadequate surgical margin was confirmed. Factors affecting survival were assessed using Cox regression. Propensity score stratification analysis was also performed. Eight patients (8%) were identified as a histological type other than adenocarcinoma or squamous cell carcinoma. Moreover, 14 patients (14%) displayed lymph node metastasis. Among those who underwent segmentectomy, nine patients (16%) were converted to lobectomy due to lymph node metastasis or inadequate surgical margin. The 3-year recurrence-free survival rates were 84.1 and 82.2% in patients who underwent segmentectomy and lobectomy, respectively (P = 0.745). In addition, the recurrence-free survival was not statistically significant between segmentectomy and lobectomy, as determined via multivariable Cox regression analysis (hazard ratio 1.11; 95% confidence interval 0.40-3.06), even after propensity score stratification (hazard ratio 1.17; 95% confidence interval 0.38-3.65). Segmentectomy with intraoperative assessment of lymph node metastasis and adequate surgical margin may be a feasible surgical procedure for pure solid tumors in clinical T1a-bN0M0 lung cancer.

UI MeSH Term Description Entries
D008175 Lung Neoplasms Tumors or cancer of the LUNG. Cancer of Lung,Lung Cancer,Pulmonary Cancer,Pulmonary Neoplasms,Cancer of the Lung,Neoplasms, Lung,Neoplasms, Pulmonary,Cancer, Lung,Cancer, Pulmonary,Cancers, Lung,Cancers, Pulmonary,Lung Cancers,Lung Neoplasm,Neoplasm, Lung,Neoplasm, Pulmonary,Pulmonary Cancers,Pulmonary Neoplasm
D008207 Lymphatic Metastasis Transfer of a neoplasm from its primary site to lymph nodes or to distant parts of the body by way of the lymphatic system. Lymph Node Metastasis,Lymph Node Metastases,Lymphatic Metastases,Metastasis, Lymph Node
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011013 Pneumonectomy The excision of lung tissue including partial or total lung lobectomy. Bronchoscopic Lung Volume Reduction,Endoscopic Lung Volume Reduction,Lung Volume Reduction,Lung Volume Reduction Surgery,Partial Pneumonectomy,Partial Pneumonectomies,Pneumonectomies,Pneumonectomy, Partial,Reduction, Lung Volume,Volume Reduction, Lung
D002289 Carcinoma, Non-Small-Cell Lung A heterogeneous aggregate of at least three distinct histological types of lung cancer, including SQUAMOUS CELL CARCINOMA; ADENOCARCINOMA; and LARGE CELL CARCINOMA. They are dealt with collectively because of their shared treatment strategy. Carcinoma, Non-Small Cell Lung,Non-Small Cell Lung Cancer,Non-Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinoma,Nonsmall Cell Lung Cancer,Carcinoma, Non Small Cell Lung,Carcinomas, Non-Small-Cell Lung,Lung Carcinoma, Non-Small-Cell,Lung Carcinomas, Non-Small-Cell,Non Small Cell Lung Carcinoma,Non-Small-Cell Lung Carcinomas
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000072662 Margins of Excision The edges of tissue removed in a surgery for assessment of the effectiveness of a surgical procedure in achieving the local control of a neoplasm and the adequacy of tumor removal. When the margin is negative or not involved by tumor (e.g., CANCER) it suggests all of the tumor has been removed by the surgery. Negative Surgical Margins,Positive Surgical Margins,Resection Margin,Surgical Margins,Tumor-Free Margins,Excision Margin,Excision Margins,Margin, Resection,Margin, Surgical,Margin, Tumor-Free,Margins, Resection,Margins, Surgical,Margins, Tumor-Free,Negative Surgical Margin,Positive Surgical Margin,Resection Margins,Surgical Margin,Surgical Margin, Negative,Surgical Margin, Positive,Surgical Margins, Negative,Surgical Margins, Positive,Tumor Free Margins,Tumor-Free Margin
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
October 2023, European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
April 2016, The Annals of thoracic surgery,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
November 2019, Journal of cardiothoracic surgery,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
September 2023, Interdisciplinary cardiovascular and thoracic surgery,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
April 2023, Thoracic cancer,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
November 2023, Interdisciplinary cardiovascular and thoracic surgery,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
February 2016, The Annals of thoracic surgery,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
April 2024, Thoracic cancer,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
January 2022, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Norifumi Tsubokawa, and Yasuhiro Tsutani, and Yoshihiro Miyata, and Yoshinori Handa, and Keizo Misumi, and Hideaki Hanaki, and Eisuke Hida, and Morihito Okada
December 2020, European journal of cardio-thoracic surgery : official journal of the European Association for Cardio-thoracic Surgery,
Copied contents to your clipboard!